サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1635854

PEG化タンパク質市場レポート：製品別、タンパク質タイプ別、用途別、エンドユーザー別、地域別、2025-2033年

PEGylated Proteins Market Report by Product, Protein Type, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 125 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
PEG化タンパク質市場レポート：製品別、タンパク質タイプ別、用途別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年01月10日
発行: IMARC
ページ情報: 英文 125 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

PEG化タンパク質市場の世界市場規模は2024年に14億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに30億米ドルに達し、2025年から2033年の間に8.43%の成長率（CAGR）を示すと予測しています。世界市場の主な原動力は、治療効果の向上、PEG化技術の進歩、慢性疾患の世界の増加であり、治療結果の改善と薬効の持続をもたらすバイオ医薬品への旺盛な投資を後押ししています。

PEG化タンパク質は、ポリエチレングリコール（PEG）との共有結合によって修飾された生体分子です。PEG化技術は、生体分子のコンフォメーション、静電結合、疎水性などの物理的・化学的特性を変化させることにより、医薬品の薬物動態学的挙動を改善します。PEG化タンパク質は、ワクチン、ホルモン補充療法、遺伝性疾患、貧血、血液凝固障害などの治療用途に広く使用されています。また、腎臓病、多発性硬化症、血友病、がんを含む様々な病気の治療薬にも使用されています。PEG化タンパク質は、半減期の延長、安定性、溶解性の向上、タンパク質分解保護、腎排泄、免疫原性、毒性の低減、ドラッグデリバリーの有効性の向上に役立ちます。このほか、PEG化タンパク質は無毒性、水溶性、親水性、非抗原性、非免疫原性です。

PEG化タンパク質市場動向：

腎臓疾患、自己免疫疾患、遺伝性疾患、肝炎、関節リウマチなどの慢性疾患の世界の流行増加は、市場成長を促進する重要な要因の一つです。PEG化タンパク質は、炎症の治療、細胞への修正遺伝子の送達、血栓の予防、成長ホルモンの送達、慢性腎臓病の進行予防などに広く使用されています。これに伴い、化学療法薬をがん細胞に直接送達し、健康な細胞への副作用を軽減するために、がん治療で広く製品が利用されていることが、市場の成長を後押ししています。これとは別に、より小さく複雑な分子を製造できる新しいPEG化法の開発など、PEG化技術におけるさまざまな改良が市場成長に弾みをつけています。さらに、コロニー刺激因子（CSF）の安定性と半減期を改善し、治療薬としての効果を高めるためにPEG化が広く採用されていることも、成長を促進する要因となっています。さらに、非タンパク質ベースの薬剤よりもタンパク質ベースの薬剤の採用が増加しており、PEG化によってタンパク質の循環と半減期が増加し、効率が向上していることも市場成長を促進しています。PEG化タンパク質の製品承認数の増加、バイオテクノロジーと分子生物学工学分野の開発、バイオ医薬品におけるPEG分子の統合と関連する利点、老人人口の増加、製薬業界の規制基準を高めるためのさまざまな政府イニシアチブの実施など、その他の要因も市場のさらなる成長を後押しすると予想されます。

本レポートで扱う主な質問

  • PEG化タンパク質市場の世界市場規模は？
  • 2025-2033年における世界のPEG化タンパク質市場の予想成長率は？
  • 世界のPEG化タンパク質市場を牽引する主要因は何か？
  • 世界のPEG化タンパク質市場に対するCOVID-19の影響は？
  • 世界のPEG化タンパク質市場の製品別内訳は？
  • 世界のPEG化タンパク質市場のタンパク質タイプ別内訳は？
  • 世界のPEG化タンパク質市場の用途別内訳は？
  • 世界のPEG化タンパク質市場のエンドユーザー別の内訳は？
  • PEG化タンパク質市場の世界における主要地域は？
  • 世界のPEG化タンパク質市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のPEG化タンパク質市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 消耗品
    • 市場動向
    • 主要セグメント
      • PEG化試薬
      • PEG化キット
    • 市場予測
  • サービス
    • 市場動向
    • 市場予測

第7章 市場内訳：タンパク質タイプ別

  • コロニー刺激因子
    • 市場動向
    • 市場予測
  • インターフェロン
    • 市場動向
    • 市場予測
  • エリスロポエチン
    • 市場動向
    • 市場予測
  • モノクローナル抗体
    • 市場動向
    • 市場予測
  • 組換え因子VII
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • がん治療
    • 市場動向
    • 市場予測
  • 肝炎
    • 市場動向
    • 市場予測
  • 慢性腎臓病
    • 市場動向
    • 市場予測
  • 血友病
    • 市場動向
    • 市場予測
  • 多発性硬化症
    • 市場動向
    • 市場予測
  • 胃腸障害
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 製薬・バイオテクノロジー企業
    • 市場動向
    • 市場予測
  • CRO
    • 市場動向
    • 市場予測
  • 学術研究機関
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第11章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abcam plc
    • Biomatrik Inc.
    • Creative PEGWorks
    • Iris Biotech GmbH
    • JenKem Technology USA Inc.
    • Laysan Bio Inc.
    • NOF America Corporation（NOF Corporation）
    • Profacgen
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: PEGylated Proteins Market: Major Drivers and Challenges
  • Figure 2: Global: PEGylated Proteins Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: PEGylated Proteins Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: PEGylated Proteins Market: Breakup by Product (in %), 2024
  • Figure 5: Global: PEGylated Proteins Market: Breakup by Protein Type (in %), 2024
  • Figure 6: Global: PEGylated Proteins Market: Breakup by Application (in %), 2024
  • Figure 7: Global: PEGylated Proteins Market: Breakup by End User (in %), 2024
  • Figure 8: Global: PEGylated Proteins Market: Breakup by Region (in %), 2024
  • Figure 9: Global: PEGylated Proteins (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: PEGylated Proteins (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: PEGylated Proteins (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: PEGylated Proteins (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: PEGylated Proteins (Colony Stimulating Factors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: PEGylated Proteins (Colony Stimulating Factors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: PEGylated Proteins (Interferons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: PEGylated Proteins (Interferons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: PEGylated Proteins (Erythropoietin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: PEGylated Proteins (Erythropoietin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: PEGylated Proteins (mAbs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: PEGylated Proteins (mAbs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: PEGylated Proteins (Recombinant Factor VII) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: PEGylated Proteins (Recombinant Factor VII) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: PEGylated Proteins (Other Protein Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: PEGylated Proteins (Other Protein Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: PEGylated Proteins (Cancer Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: PEGylated Proteins (Cancer Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: PEGylated Proteins (Hepatitis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: PEGylated Proteins (Hepatitis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: PEGylated Proteins (Chronic Kidney Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: PEGylated Proteins (Chronic Kidney Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: PEGylated Proteins (Hemophilia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: PEGylated Proteins (Hemophilia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: PEGylated Proteins (Multiple Sclerosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: PEGylated Proteins (Multiple Sclerosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: PEGylated Proteins (Gastrointestinal Disorders) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: PEGylated Proteins (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: PEGylated Proteins (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: PEGylated Proteins (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: PEGylated Proteins (Contract Research Organizations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: PEGylated Proteins (Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: PEGylated Proteins (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: PEGylated Proteins (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: North America: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: North America: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: United States: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: United States: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Canada: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Canada: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Asia-Pacific: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Asia-Pacific: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: China: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: China: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Japan: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Japan: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: India: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: India: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: South Korea: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: South Korea: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Australia: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Australia: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Indonesia: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Indonesia: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Europe: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Europe: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Germany: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Germany: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: France: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: France: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: United Kingdom: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: United Kingdom: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Italy: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Italy: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Spain: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Spain: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Russia: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Russia: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Latin America: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Latin America: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Brazil: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Brazil: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Mexico: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Mexico: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Others: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Others: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Middle East and Africa: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Middle East and Africa: PEGylated Proteins Market: Breakup by Country (in %), 2024
  • Figure 93: Middle East and Africa: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 94: Global: PEGylated Proteins Industry: Drivers, Restraints, and Opportunities
  • Figure 95: Global: PEGylated Proteins Industry: Value Chain Analysis
  • Figure 96: Global: PEGylated Proteins Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: PEGylated Proteins Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: PEGylated Proteins Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: PEGylated Proteins Market Forecast: Breakup by Protein Type (in Million USD), 2025-2033
  • Table 4: Global: PEGylated Proteins Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: PEGylated Proteins Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: PEGylated Proteins Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: PEGylated Proteins Market: Competitive Structure
  • Table 8: Global: PEGylated Proteins Market: Key Players
目次
Product Code: SR112024A7070

The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.0 Billion by 2033, exhibiting a growth rate (CAGR) of 8.43% during 2025-2033. The global market is primarily driven by their enhanced therapeutic efficacy, advancements in PEGylation technologies, and the rising global prevalence of chronic diseases, fueling robust investments in biopharmaceuticals that offer improved treatment outcomes and sustained drug performance.

PEGylated proteins are biomolecules that have been modified by covalent conjugation with polyethylene glycol (PEG). It involves the PEGylation technique that improves the pharmacokinetic behavior of the medicine by altering the biological molecule's physical and chemical characteristics, such as its conformation, electrostatic binding, and hydrophobicity. PEGylated proteins are widely used in therapeutic applications, such as vaccines, hormone replacement therapy, genetic disorders, anemia, and blood clotting disorder. It is also used in various drugs for diseases, including kidney disease, multiple sclerosis, hemophilia, and cancers. PEGylated proteins help in the extension of half-life, increasing stability, solubility, and proteolytic protection, reducing renal excretion, immunogenicity, and toxicity, and enhancing the efficacy of drug delivery. Besides this, PEGylated proteins are non-toxic, water-soluble, hydrophilic, non-antigenic, and non-immunogenic.

PEGylated Proteins Market Trends:

The rising prevalence of chronic diseases, such as kidney ailments, autoimmune diseases, genetic disorders, hepatitis, and rheumatoid arthritis across the globe is one of the key factors driving the market growth. PEGylated proteins are widely used to treat inflammation, deliver corrective genes to cells, prevent blood clots, deliver growth hormones, and prevent the progression of chronic kidney disease. In line with this, the widespread product utilization in cancer treatment to deliver chemotherapy drugs directly to cancer cells and reduce the side effects on healthy cells is favoring the market growth. Apart from this, various improvements in the PEGylation technology, such as the development of new PEGylation methods that can produce smaller and more complex molecules, are providing an impetus to the market growth. Additionally, the widespread adoption of PEGylation to improve the stability and half-life of colony-stimulating factors (CSFs), making them more effective as therapeutic agents, is acting as another growth-inducing factor. Furthermore, the rising adoption of protein-based drugs over non-protein-based drugs wherein PEGylation increases the circulation and half-life of the proteins, improving its efficiency, is propelling the market growth. Other factors, including the increasing number of product approvals for PEGylated proteins, development in the field of biotechnology and molecular biology engineering, the integration of PEG molecules in biopharmaceuticals and the associated advantages, rising geriatric population, and the implementation of various government initiatives to increase regulatory standards in the pharmaceutical industry, are anticipated drive the market further toward growth.

Key Market Segmentation:

Product Insights:

  • Consumables
  • PEGylation Reagents
  • PEGylation Kits
  • Services
  • A detailed breakup and analysis of the PEGylated proteins market based on the product has also been provided in the report. This includes consumables (PEgylation reagents and PEgylation kits) and services. According to the report, consumables accounted for the largest market share.

Protein Type Insights:

  • Colony Stimulating Factors
  • Interferons
  • Erythropoietin
  • mAbs
  • Recombinant Factor VII
  • Others

Application Insights:

  • Cancer Treatment
  • Hepatitis
  • Chronic Kidney Diseases
  • Hemophilia
  • Multiple Sclerosis
  • Gastrointestinal Disorders
  • Others

End User Insights:

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Academic and Research Institutes

Regional Insights:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for PEGylated proteins. Some of the factors driving the North America PEGylated proteins market included the rising geriatric population, increasing prevalence of chronic diseases, and extensive research and development (R&D).

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global PEGylated proteins market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abcam plc, Biomatrik Inc., Creative PEGWorks, Iris Biotech GmbH, JenKem Technology USA Inc., Laysan Bio Inc., NOF America Corporation (NOF Corporation), Profacgen, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report

  • 1. How big is the global PEGylated proteins market?
  • 2. What is the expected growth rate of the global PEGylated proteins market during 2025-2033?
  • 3. What are the key factors driving the global PEGylated proteins market?
  • 4. What has been the impact of COVID-19 on the global PEGylated proteins market?
  • 5. What is the breakup of the global PEGylated proteins market based on the product?
  • 6. What is the breakup of the global PEGylated proteins market based on the protein type?
  • 7. What is the breakup of the global PEGylated proteins market based on the application?
  • 8. What is the breakup of the global PEGylated proteins market based on the end user?
  • 9. What are the key regions in the global PEGylated proteins market?
  • 10. Who are the key players/companies in the global PEGylated proteins market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global PEGylated Proteins Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 PEGylation Reagents
      • 6.1.2.2 PEGylation Kits
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Protein Type

  • 7.1 Colony Stimulating Factors
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Interferons
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Erythropoietin
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 mAbs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Recombinant Factor VII
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Cancer Treatment
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hepatitis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Chronic Kidney Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Hemophilia
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Multiple Sclerosis
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Gastrointestinal Disorders
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Contract Research Organizations
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abcam plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Biomatrik Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Creative PEGWorks
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Iris Biotech GmbH
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 JenKem Technology USA Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Laysan Bio Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 NOF America Corporation (NOF Corporation)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Profacgen
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Thermo Fisher Scientific Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report